Search Results - Sandoz,

Refine Results
  1. 1

    Novartis' Sandoz: Between Generics and Pharma

    Authors: Carin-Isabel Knoop Krishna G. Palepu

    Resource Type: eBook.

    Categories: BUSINESS & ECONOMICS / General

    PDF Full Text
    Save to List
  2. 2

    Willa Cather and Mari Sandoz: The Muse and the Story Catcher in the Capital City.

    Authors: KETCHAM, SALLIE

    Source: Cather Studies. 2025, Vol. 14, p203-233. 31p.

    PDF Full Text
    Save to List
  3. 3

    MarketLine Company Profile: Sandoz International GmbH.

    Source: Sandoz International GmbH MarketLine Company Profile. 11/26/2024, p1-29. 29p.

    PDF Full Text
    Save to List
  4. 4

    Sandoz Studies, Volume 1 : Women in the Writings of Mari Sandoz

    Authors: Renée M. Laegreid Shannon D. Smith

    Resource Type: eBook.

    Subjects: Women in literature

    Categories: LITERARY CRITICISM / American / General, HISTORY / United States / State & Local / Midwest (IA, IL, IN, KS, MI, MN, MO, ND, NE, OH, SD, WI), LITERARY CRITICISM / Women Authors

    PDF Full Text ePub Full Text
    Save to List
  5. 5

    Sandoz CEO Views Trump's Tariff Threat on Generic Drugs as Opportunity.

    Authors: Demetz, Isabel Burden, Lizzy

    Source: Bloomberg.com. 8/5/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  6. 6

    Le fantastique de Maurice Sandoz : Le cas du Labyrinthe. (French)

    Authors: Van Cutsem, Pierre1, pierre.van_cutsem@us.edu.pl

    Source: Acta Universitatis Lodziensis: Folia Litteraria Romanica; 2023, Vol. 18, p199-211, 13p

    PDF Full Text
    Save to List
  7. 7

    Letters of Mari Sandoz

    Authors: Mari Sandoz Helen Winter Stauffer

    Resource Type: eBook.

    Subjects: Western stories--Authorship, Authors, American--20th century--Correspondence

    Categories: LITERARY COLLECTIONS / Letters, LITERARY CRITICISM / General

    PDF Full Text
    Save to List
  8. 8

    Sandoz International GmbH. SWOT Analysis.

    Source: Sandoz International GmbH SWOT Analysis. 11/26/2024, p1-7. 7p.

    PDF Full Text
    Save to List
  9. 9

    MarketLine Company Profile: Sandoz International GmbH.

    Source: Sandoz International GmbH MarketLine Company Profile. 9/4/2023, p1-29. 29p.

    HTML Full Text PDF Full Text
    Save to List
  10. 10

    Sandoz Targets $650 Billion Opportunity With Biosimilars Unit.

    Authors: Demetz, Isabel Doenecke, Paula

    Source: Bloomberg.com. 3/10/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  11. 11

    Sandoz International GmbH SWOT Analysis.

    Source: Sandoz International GmbH SWOT Analysis. 9/4/2023, p1-7. 7p.

    PDF Full Text
    Save to List
  12. 12

    Sandoz investit 300 M$ à Ljubljana.

    Source: Actulabo. 9/16/2026, Issue 506, p5-6. 2p.

    HTML Full Text PDF Full Text
    Save to List
  13. 13

    MarketLine Company Profile: Sandoz International GmbH.

    Source: Sandoz International GmbH MarketLine Company Profile. 3/16/2022, p1-28. 28p.

    HTML Full Text PDF Full Text
    Save to List
  14. 14

    Antibiotics Must Cost More Than M&Ms, Sandoz Tells Governments.

    Authors: Doenecke, Paula (AUTHOR)

    Source: Bloomberg.com. 10/30/2025, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  15. 15

    MarketLine Company Profile: Sandoz International GmbH.

    Source: Sandoz International GmbH MarketLine Company Profile. 2/8/2021, p1-27. 27p.

    HTML Full Text PDF Full Text
    Save to List
  16. 16

    MarketLine Company Profile: Sandoz International GmbH.

    Source: Sandoz International GmbH MarketLine Company Profile. 11/20/2020, p1-27. 27p.

    HTML Full Text PDF Full Text
    Save to List
  17. 17

    SANDOZ INC. V. AMGEN INC.: REMOVING BARRIERS TO MARKET ACCESS FOR BIOSIMILAR MANUFACTURERS.

    Authors: KOYA, MOYOSORE O.1

    Source: Journal of Health Care Law & Policy. 2019, Vol. 22 Issue 2, p75-98. 24p.

    PDF Full Text
    Save to List
  18. 18

    Sandoz International GmbH SWOT Analysis.

    Source: Sandoz International GmbH SWOT Analysis. 3/16/2022, p1-7. 7p.

    PDF Full Text
    Save to List
  19. 19

    Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform.

    Source: Pharma Business Week. 9/4/2026, p1381-1381. 1p.

    HTML Full Text
    Save to List
  20. 20

    Sandoz se positionne face à Hemlibra.

    Source: Actulabo. 10/14/2026, Issue 508, p3-3. 1/9p.

    HTML Full Text PDF Full Text
    Save to List

Search Tools: